HCW Biologics Inc.
HCWB
$6.02
$0.132.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 29.41% | -98.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 29.41% | -98.71% | |||
| Cost of Revenue | 26.83% | -98.70% | |||
| Gross Profit | 30.00% | -98.73% | |||
| SG&A Expenses | -9.88% | -28.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.60% | -18.20% | |||
| Operating Income | 12.65% | 11.08% | |||
| Income Before Tax | 12.25% | 34.87% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 12.25% | 34.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.25% | 34.87% | |||
| EBIT | 12.65% | 11.08% | |||
| EBITDA | 10.56% | 6.10% | |||
| EPS Basic | -245.04% | 38.33% | |||
| Normalized Basic EPS | 45.04% | 14.97% | |||
| EPS Diluted | -245.04% | 38.33% | |||
| Normalized Diluted EPS | 45.04% | 14.97% | |||
| Average Basic Shares Outstanding | 59.38% | 5.62% | |||
| Average Diluted Shares Outstanding | 59.38% | 5.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||